Sign In
Buy HIMS
$27.51
+0 (+0%)
At Close: Jun 03, 2026
3 Sector Stars Lead Growth: Foot Locker, Shake Shack, Hims & Hers
07:25am, Monday, 10'th Jun 2024
One of the market's most closely watched economic reports made a sudden turn last week. The employment situation report (NFP) showed that the U.S. economy is still resiliently adding jobs despite seei
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know
10:05am, Friday, 07'th Jun 2024
Recently, Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes it worthwhile to examine what the stock has in store.
5 Phenomenal Relative Price Strength Stocks to Snap Up Now
08:50am, Thursday, 06'th Jun 2024
VITL, HIMS, ANF, CHWY and GPS are five stocks with explosive relative price strength.
Hims & Hers Health Soars on Generic GLP-1 Rollout Plans
07:42am, Monday, 03'rd Jun 2024
Him & Hers Health Inc. NYSE: HIMS provides a direct-to-consumer (DTC) health and wellness platform. The company was best known for prescribing treatments for erectile dysfunction (ED) through brand an
Hims & Hers Health Stock Soared This Week: Here's Why
09:22am, Saturday, 01'st Jun 2024
Hims & Hers recently launched weight loss drugs at a disruptive price point. The company is growing revenue quickly.
Call Option Volumes Spiked For These 3 Stocks
07:00am, Thursday, 30'th May 2024
As the saying goes, always follow the money. This time, investors can follow the proverbial big players through an options activity screener, spotting unusual trends in how markets are betting.
3 Medical Info Systems Stocks to Buy as GenAI Transforms Healthcare
12:26pm, Tuesday, 28'th May 2024
Zacks Medical Info Systems industry stocks like Hims & Hers Health (HIMS), Enovis Corporation (ENOV) and Health Catalyst (HCAT) are expected to gain from the GenAI wave.
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It
10:06am, Monday, 27'th May 2024
Hims & Hers Health (HIMS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
The Ultimate Growth Stock to Buy With $20 Right Now
08:15am, Sunday, 26'th May 2024
Hims & Hers has entered the popular GLP-1 agonist category. Weight loss has quickly become a significant, potentially unexpected catalyst.
7 Stocks to Dominate in the Next Economic Upturn
09:28am, Friday, 24'th May 2024
If you're wondering which stocks to buy for the next economic upturn, you're in the right place. Finding profitable investment opportunities in the constantly changing global economy is crucial to pro
The Growth Stock Shuffle: 2 to Ditch and 1 to Own
12:42pm, Wednesday, 22'nd May 2024
Judging which growth stocks are good long-term bets is trickier than you might expect. These fast-moving businesses can be hard to forecast, and changes in their broader industries could quickly lift�
Hims & Hers Is Changing the Game
04:36am, Wednesday, 22'nd May 2024
GLP-1s could be the product that pushes Hims & Hers over the edge to mainstream adoption.
Hims & Hers rolls out weight-loss shots much cheaper than Ozempic, Wegovy
02:35pm, Tuesday, 21'st May 2024
Health and wellness company Hims & Hers announced Monday that it is introducing injectable weight-loss drugs at a fraction of the cost of Ozempic and Wegovy.
Hims & Hers Health stock price nears record high on news that it will offer GLP-1 weight-loss drugs amid shortages
10:51am, Tuesday, 21'st May 2024
Hims & Hers Health got a shot in the arm this week that sent its share prices to near all-time highs.
Hims & Hers: Soaring On Access To Compounded GLP-1 Drugs, Further Volatility Ahead
08:15am, Tuesday, 21'st May 2024
Hims & Hers Health's share price increased by over 25% after announcing the availability of compounded GLP-1 agonist weight loss drugs at a fraction of the price of branded drugs. The company aims to
